1887
Preview this article:
Zoom in
Zoomout

Career thoughts and recollections: 50 years of publishing in the , Page 1 of 1

| /docserver/preview/fulltext/jgv/100/10/1390_vir001311-1.gif

There is no abstract available for this article.
Use the preview function to the left.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/jgv.0.001311
2019-10-01
2019-10-15
Loading full text...

Full text loading...

/deliver/fulltext/jgv/100/10/1390.html?itemId=/content/journal/jgv/10.1099/jgv.0.001311&mimeType=html&fmt=ahah

References

  1. Rowlands DJ, Cartwright B, Brown F. Evidence for an internal antigen in foot-and-mouth disease virus. J Gen Virol 1969;4:479–487 [CrossRef]
    [Google Scholar]
  2. Burroughs JN, Rowlands DJ, Sangar DV, Talbot P, Brown F. Further evidence for multiple proteins in the foot-and-mouth disease virus particle. J Gen Virol 1971;13:73–84 [CrossRef]
    [Google Scholar]
  3. Newman JF, Rowlands DJ, Brown F. A physico-chemical sub-grouping of the mammalian picornaviruses. J Gen Virol 1973;18:171–180
    [Google Scholar]
  4. Picornaviridae. http://www.picornaviridae.com/. 14 March 2019
  5. Sangar DV, Black DN, Rowlands DJ, Brown F. Biochemical mapping of the foot-and-mouth disease virus genome. J Gen Virol 1977;35:281–297 [CrossRef]
    [Google Scholar]
  6. Bittle JL, Houghten RA, Alexander H, Shinnick TM, Sutcliffe JG et al. Protection against foot-and-mouth disease by immunization with a chemically synthesized peptide predicted from the viral nucleotide sequence. Nature 1982;298:30–33 [CrossRef]
    [Google Scholar]
  7. Acharya R, Fry E, Stuart D, Fox G, Rowlands D et al. The three-dimensional structure of foot-and-mouth disease virus at 2.9 A resolution. Nature 1989;337:709–716 [CrossRef]
    [Google Scholar]
  8. Logan D, Abu-Ghazaleh R, Blakemore W, Curry S, Jackson T et al. Structure of a major immunogenic site on foot-and-mouth disease virus. Nature 1993;362:566–568 [CrossRef]
    [Google Scholar]
  9. Francis MJ, Hastings GZ, Syred AD, McGinn B, Brown F et al. Non-Responsiveness to a foot-and-mouth disease virus peptide overcome by addition of foreign helper T-cell determinants. Nature 1987;330:168–170 [CrossRef]
    [Google Scholar]
  10. Clarke BE, Newton SE, Carroll AR, Francis MJ, Appleyard G et al. Improved immunogenicity of a peptide epitope after fusion to hepatitis B core protein.. Nuc Acids Res 1987;12:2461–2472
    [Google Scholar]
  11. Rowlands DJ. Foot-and-mouth disease viruses Encyclopedia of Virology2, Third Edition. 2008; pp265–274
    [Google Scholar]
  12. Clarke BE, Sangar DV, Burroughs JN, Newton SE, Carroll AR et al. Two initiation sites for FMDV polyprotein in vivo. J.Gen.Virol 1985;66:2615–2626
    [Google Scholar]
  13. Newton SE, Carroll AR, Campbell RA, Clarke BE, Rowlands DJ. The sequence of FMDV RNA to the 5` side of the poly (C) tract. Gene 1985;40:331–336
    [Google Scholar]
  14. Clarke BE, Brown AL, Currey KM, Newton SE, Rowlands DJ et al. Potential secondary and tertiary structure in the genomic RNA of foot and mouth disease virus. Nucleic Acids Res 1987;15:7067–7079 [CrossRef]
    [Google Scholar]
  15. Choo QL, Weiner AJ, Overby LR, Kuo G, Houghton M et al. Hepatitis C virus: the major causative agent of viral non-A, non-B hepatitis. Br Med Bull 1990;46:423–441 [CrossRef]
    [Google Scholar]
  16. D'Souza ED, Grace K, Sangar DV, Rowlands DJ, Clarke BE. In vitro cleavage of hepatitis C virus polyprotein substrates by purified recombinant NS3 protease. J Gen Virol 1995;76:1729–1736 [CrossRef]
    [Google Scholar]
  17. Aoubala M, Holt J, Clegg RA, Rowlands DJ, Harris M. The inhibition of cAMP-dependent protein kinase by full-length hepatitis C virus NS3/4A complex is due to ATP hydrolysis. J Gen Virol 2001;82:1637–1646 [CrossRef]
    [Google Scholar]
  18. O'Farrell D, Trowbridge R, Rowlands D, Jäger J. Substrate complexes of hepatitis C virus RNA polymerase (HC-J4): structural evidence for nucleotide import and de-novo initiation. J Mol Biol 2003;326:1025–1035 [CrossRef]
    [Google Scholar]
  19. Griffin SDC, Beales LP, Clarke DS, Worsfold O, Evans SD et al. The p7 protein of hepatitis C virus forms an ion channel that is blocked by the antiviral drug, amantadine. FEBS Lett 2003;535:34–38 [CrossRef]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/jgv.0.001311
Loading
/content/journal/jgv/10.1099/jgv.0.001311
Loading

Data & Media loading...

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error